These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. The pharmacologic elegance of inhibiting cholesterol absorption and synthesis while providing a homeostatic balance. Catapano AL Fundam Clin Pharmacol; 2007 Nov; 21 Suppl 2():21-6. PubMed ID: 18001316 [TBL] [Abstract][Full Text] [Related]
8. [Cholesterol absorption as a target for the treatment of hypercholesterolemia]. Bitzur R; Cohen H; Harats D Harefuah; 2006 Nov; 145(11):831-5, 861, 860. PubMed ID: 17183957 [TBL] [Abstract][Full Text] [Related]
9. Baseline intestinal absorption and synthesis of cholesterol regulate its response to hypolipidaemic treatments in coronary patients. Gylling H; Miettinen TA Atherosclerosis; 2002 Feb; 160(2):477-81. PubMed ID: 11849674 [TBL] [Abstract][Full Text] [Related]
10. Cholesterol absorption and synthesis in children with type 1 diabetes. Järvisalo M; Raitakari O; Gylling H; Miettinen TA Diabetes Care; 2006 Oct; 29(10):2300-4. PubMed ID: 17003310 [TBL] [Abstract][Full Text] [Related]
11. [Distinction between good synthesizer and good absorber patients to optimize cholesterol-lowering therapy]. Radermecker RP; Scheen AJ Rev Med Suisse; 2006 Aug; 2(76):1910-5. PubMed ID: 16972541 [TBL] [Abstract][Full Text] [Related]
12. Impact of quality of dietary fat on serum cholesterol and coronary heart disease: focus on plant sterols and other non-glyceride components. Ghafoorunissa Natl Med J India; 2009; 22(3):126-32. PubMed ID: 19764688 [TBL] [Abstract][Full Text] [Related]
13. The effect of exogenous cholesterol and lipid-modulating agents on enterocytic amyloid-beta abundance. Pallebage-Gamarallage MM; Galloway S; Johnsen R; Jian L; Dhaliwal S; Mamo JC Br J Nutr; 2009 Feb; 101(3):340-7. PubMed ID: 18631412 [TBL] [Abstract][Full Text] [Related]
14. Effects of ezetimibe/simvastatin on lipoprotein subfractions in patients with primary hypercholesterolemia: an exploratory analysis of archived samples using two commercially available techniques. Ose L; Reyes R; Johnson-Levonas AO; Sapre A; Tribble DL; Musliner T Clin Ther; 2007 Nov; 29(11):2419-32. PubMed ID: 18158082 [TBL] [Abstract][Full Text] [Related]
15. [Dual inhibition of cholesterol using the drug combination ezetimibe/simvastatin?]. Vaverková H Vnitr Lek; 2007 Apr; 53(4):421-7. PubMed ID: 17578178 [TBL] [Abstract][Full Text] [Related]
16. Reduction in estimated risk for coronary artery disease after use of ezetimibe with a statin. Sampalis JS; Bissonnette S; Habib R; Boukas S; Ann Pharmacother; 2007 Sep; 41(9):1345-51. PubMed ID: 17666579 [TBL] [Abstract][Full Text] [Related]
17. Treatment with ezetimibe plus low-dose atorvastatin compared with higher-dose atorvastatin alone: is sufficient cholesterol-lowering enough to inhibit platelets? Piorkowski M; Fischer S; Stellbaum C; Jaster M; Martus P; Morguet AJ; Schultheiss HP; Rauch U J Am Coll Cardiol; 2007 Mar; 49(10):1035-42. PubMed ID: 17349882 [TBL] [Abstract][Full Text] [Related]
20. [Therapy of dyslipidemia in post-infarction: state of the art]. Borgia MC; Nardi M; Da Ros S; Castellano V Clin Ter; 2007; 158(6):523-32. PubMed ID: 18265719 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]